Exercise program aims to restore strength after dengue and chikungunya

NCT ID NCT07600879

Not yet recruiting Symptom relief Sponsor: Universidade do Estado do Pará Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 20-session exercise program can improve muscle strength, reduce fatigue, and help with balance in people who had dengue or chikungunya in the last five years. Fifty-four adults will do supervised aerobic, strength, and breathing exercises twice a week. The goal is to see if this rehab can ease long-lasting symptoms and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Exercise rehabilitation (aerobic, anaerobic, and respiratory training)
What this could lead to: If it works, this could point toward a standard rehab program to help people recover muscle strength, reduce fatigue, and improve balance after dengue or chikungunya.
What could go wrong: This is a small, early-stage trial with only 54 participants and no randomization, so results may not apply to everyone. The exercises are supervised and generally safe, but some people may find them too intense.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chikungunya dengue disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHIKUNGUNYA DENGUE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Universidade Do Estado Do Pará

Belém, Pará, 66.087-670, Brazil

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.